细胞外囊泡用于前列腺癌液体活检:现状与未来方向
本文综述了模型系统和患者生物体液中前列腺癌来源细胞外囊泡(EV)的分子特征,讨论了基于EV的液体活检在蛋白质、DNA和RNA层面的优势与局限。目前已鉴定出若干候选生物标志物,但难以应用于临床;该领域正朝着分离无良性EV和囊外污染物污染的癌症特异性EV的新工具方向发展。
要点
- EV分析在前列腺癌非侵入性生物标志物开发方面具有很大前景。
- 已鉴定若干候选生物标志物,但这些结果难以应用于临床。
- 需要现代EV分离与表征方法以在体内 interrogate 循环EV。
核心结论
- EV分析在前列腺癌患者非侵入性生物标志物开发方面具有很大前景。
- 现代EV分离与表征方法的实施将能够 interrogate 体内循环EV。
研究设计与样本
- 本文为综述,检索并总结了模型系统和患者生物体液中前列腺癌来源EV分子谱的当前文献。
主要发现
- 已鉴定出若干候选生物标志物,但这些结果难以应用于临床。
- 该领域正迅速朝着实施新工具方向发展,以分离无良性EV和囊外污染物污染的癌症特异性EV。
- 通过鉴定肿瘤细胞来源EV中精确存在的标志物可实现癌症特异性EV的分离。
- 更好地理解可能在肿瘤进展中发挥特定功能且可能作为癌症特异性标志物来源的EV类型也可能有重要贡献。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Extracellular vesicles (EVs) are a heterogeneous class of lipid bound particles shed by any cell in the body in physiological and pathological conditions. EVs play critical functions in intercellular communication. EVs can actively travel in intercellular matrices and eventually reach the circulation. They can also be released directly in biological fluids where they appear to be stable. Because the molecular content of EVs reflects the composition of the cell of origin, they have recently emerged as a promising source of biomarkers in a number of diseases. EV analysis is particularly attractive in cancer patients that frequently present with increased numbers of circulating EVs. METHODS: We sought to review the current literature on the molecular profile of prostate cancer-derived EVs in model systems and patient biological fluids in an attempt to draw some practical and universal conclusions on the use of EVs as a tool for liquid biopsy in clinical specimens. RESULTS: We discuss advantages and limitations of EV-based liquid biopsy approaches summarizing salient studies on protein, DNA and RNA. Several candidate biomarkers have been identified so far but these results are difficult to apply to the clinic. However, the field is rapidly moving toward the implementation of novel tools to isolate cancer-specific EVs that are free of benign EVs and extra-vesicular contaminants. This can be achieved by identifying markers that are exquisitely present in tumor cell-derived EVs. An important contribution might also derive from a better understanding of EV types that may play specific functions in tumor progression and that may be a source of cancer-specific markers. CONCLUSIONS: EV analysis holds strong promises for the development of non-invasive biomarkers in patients with prostate cancer. Implementation of modern methods for EV isolation and characterization will enable to interrogate circulating EVs in vivo.
引用
- Minciacchi VR, Zijlstra A, Rubin MA, et al. Extracellular vesicles for liquid biopsy in prostate cancer: where are we and where are we headed? Prostate Cancer Prostatic Dis. 2017. PMID: 28374743. doi:10.1038/pcan.2017.7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。